The cost-effectiveness of lifesaving interventions in Sweden

被引:0
|
作者
Center for Risk Research, Stockholm School of Economics, Box 6501, 113 83 Stockholm, Sweden [1 ]
机构
来源
RISK ANAL. | / 4卷 / 467-478期
关键词
Cost effectiveness - Statistical methods;
D O I
暂无
中图分类号
学科分类号
摘要
In this article, we discuss under what conditions an estimated cost per statistical life saved can be interpreted as an implied lifevalue. Furthermore, we state optimality conditions with respect to variation in implied lifevalues. The cost-effectiveness, together with references, are presented for 165 lifesaving interventions in Sweden. The cost-effectiveness of interventions has been found in publicly available analyses, or in some cases been calculated by us. Several of these interventions produce net savings for society. The most expensive interventions cost several hundred million SEK, or more, per life saved. To improve the comparability of the interventions, certain criteria have been used to standardize the estimates. Still, dissimilarities in the calculation of implied life values remain and the quality of the original data is in some cases uncertain. Despite this and the fact that the interventions are not a representative sample, it is nevertheless possible to conclude that implied life values vary greatly both within and between different sectors of the Swedish society, much in the same manner as in current U.S. analyses.
引用
收藏
相关论文
共 50 条
  • [1] The cost-effectiveness of lifesaving interventions in Sweden
    Ramsberg, JAL
    Sjoberg, L
    RISK ANALYSIS, 1997, 17 (04) : 467 - 478
  • [2] 500 LIFESAVING INTERVENTIONS AND THEIR COST-EFFECTIVENESS
    TENGS, TO
    ADAMS, ME
    PLISKIN, JS
    SAFRAN, DG
    SIEGEL, JE
    WEINSTEIN, MC
    GRAHAM, JD
    RISK ANALYSIS, 1995, 15 (03) : 369 - 390
  • [3] COST-EFFECTIVENESS OF ANTITUBERCULOSIS INTERVENTIONS
    CASTELO, A
    MATHIASI, PA
    IUNES, R
    KRITSKI, AL
    DALCOLMO, M
    DEMELO, FF
    DRUMMOND, M
    PHARMACOECONOMICS, 1995, 8 (05) : 385 - 399
  • [4] Cost-effectiveness of coronary interventions
    Cohen, DJ
    Sukin, CA
    HEART, 1997, 78 : 7 - 10
  • [5] COST-EFFECTIVENESS OF OBESITY INTERVENTIONS
    Veerman, Lennert
    Sacks, Gary
    Lee, Yong-Yi
    Cobiac, Linda
    Barendregt, Jan
    Vos, Theo
    Carter, Rob
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 20 - 20
  • [6] Cost-effectiveness of infliximab (Remicade) in Sweden
    Kobelt, G
    Jonsson, L
    Lindquist, E
    Eberhardt, K
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S158 - S158
  • [7] The cost-effectiveness of inhaled insulin in Sweden
    Neovius, M.
    Pruz, C.
    VALUE IN HEALTH, 2006, 9 (06) : A231 - A231
  • [8] THE COST-EFFECTIVENESS OF ROFLUMILAST FOR COPD IN SWEDEN
    Engstrom, A.
    VALUE IN HEALTH, 2011, 14 (07) : A494 - A494
  • [9] THE COST-EFFECTIVENESS OF HYPERTENSION TREATMENT IN SWEDEN
    JOHANNESSON, M
    PHARMACOECONOMICS, 1995, 7 (03) : 242 - 250
  • [10] The comparative effectiveness and cost-effectiveness of vitreoretinal interventions
    Brown, Melissa M.
    Brown, Gary C.
    Brown, Heidi C.
    Irwin, Blair
    Brown, Kathryn S.
    CURRENT OPINION IN OPHTHALMOLOGY, 2008, 19 (03) : 202 - 207